About the Author
Proxima CRO Team
Taylor Lunsford, MGA
Regulatory Associate II
Taylor is fluent in Mandarin Chinese and has a strong background in medical interpreting and translating medical documents. Before joining Proxima, Taylor served in the Army as an intelligence analyst, instructor, translator and small-unit leader.

An Investigational New Drug Application (IND) is a request from a clinical study sponsor to obtain authorization from the FDA to administer an investigational drug or biological product to humans. 

Related FAQs:
More Questions? We're here to help!
SPEAK WITH A SPECIALIST